Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-RALA Antibody (R3C50)

Catalog #:   RHC87202 Specific References (44) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM, WB
Accession: P11233
Overview

Catalog No.

RHC87202

Species reactivity

Human, Mouse, Monkey

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Applications

ELISA, FCM, WB

Recommended Dilution

Application Dilution
ELISA 1:10000, FCM: 1:200-1:400, WB: 1:500-1:2000

Target

Ras-related protein Ral-A, RAL, RALA

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P11233

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3C50

Note

For research use only.

Data Image
  • Flow Cytometry
    Flow cytometric analysis of MCF-7 cells using RALA mouse mAb (green) and negative control (red).
  • Western blot
    Western blot analysis using RALA mouse mAb against HepG2 (1), MCF-7 (2), A549 (3), K562 (4), Raji (5), MOLT4 (6), Hela (7), COS7 (8), and NIH3T3 (9) cell lysate.
References

Identification of multiple ral gene products in human platelets that account for some but not all of the platelet Gn-proteins., PMID:2105235

Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA., PMID:1903399

Identification of some of the brain Gn27 as the ral gene product. Comparison between the brain and platelet Gn-proteins., PMID:1544424

Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21., PMID:1379346

Involvement of Ral GTPase in v-Src-induced phospholipase D activation., PMID:7477381

Generation of antibodies specific for the RalA and RalB GTP-binding proteins and determination of their concentration and distribution in human platelets., PMID:8972729

Immunodetection of ralA and ralB GTP-binding proteins in various rat tissues and platelets., PMID:9543348

Small GTP-binding protein RalA associates with Weibel-Palade bodies in endothelial cells., PMID:10494784

Role for phospholipase D in receptor-mediated endocytosis., PMID:11134345

The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42., PMID:12517963

Phosphorylation of 46-kDa protein of synaptic vesicle membranes is stimulated by GTP and Ca2+/calmodulin., PMID:12526085

RalA-exocyst-dependent recycling endosome trafficking is required for the completion of cytokinesis., PMID:17028198

R-Ras regulates exocytosis by Rgl2/Rlf-mediated activation of RalA on endosomes., PMID:17344481

Large-scale quantitative LC-MS/MS analysis of detergent-resistant membrane proteins from rat renal collecting duct., PMID:18596208

Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein., PMID:19299511

Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma., PMID:19683863

Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma., PMID:19822090

Phosphorylation of RalB is important for bladder cancer cell growth and metastasis., PMID:20940393

Analyzing the function of small GTPases by microinjection of plasmids into polarized epithelial cells., PMID:21673637

Ral GTPases regulate cell-mediated cytotoxicity in NK cells., PMID:21810610

Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylation., PMID:24222664

Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer., PMID:24761876

Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens., PMID:24860838

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer., PMID:25069475

Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer., PMID:27286458

Probing Functional Changes in Exocyst Configuration with Monoclonal Antibodies., PMID:27376061

Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer., PMID:28618923

Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer., PMID:29022480

Multi-panel assay of serum autoantibodies in colorectal cancer., PMID:29691673

Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer., PMID:30484895

Development of a ZHER3-Affibody-Targeted Nano-Vector for Gene Delivery to HER3-Overexpressed Breast Cancer Cells., PMID:31531954

Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study., PMID:32574375

Prevalence of autoantibodies against Ras-like GTPases, RalA, in patients with gastric cancer., PMID:32765875

The immunophilin Zonda controls regulated exocytosis in endocrine and exocrine tissues., PMID:33336828

Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer., PMID:33363728

Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer., PMID:33605508

Absolute Quantitation of GTPase Protein Abundance., PMID:33977471

Seroprevalence of Toxocara spp. in children (3-13 years old) in Zahedan, Southeast of Iran., PMID:34295044

Development of recombinant biomimetic nano-carrier for targeted gene transfer to HER3 positive breast cancer., PMID:34455002

Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers., PMID:34632560

Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study., PMID:36238856

Awaken Immune Cells by Hapten Enhanced Intratumoral Chemotherapy with Penicillin Prolong Pancreatic Cancer Survival., PMID:37283801

Successful targeting in situ of an oncogenic nuclear antigen by hapten induced tumor associated autoantibodies (iTAA)., PMID:37336938

Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine., PMID:37648082

Datasheet

Document Download

Anti-RALA Antibody (R3C50).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-RALA Antibody (R3C50) [RHC87202]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only